Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company ImmunoBiology Ltd.
DescriptionVaccine containing heat shock proteins and multiple antigens produced by a genetically modified form of Streptococcus pneumoniae
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationPneumococcus
Indication DetailsVaccinate against invasive pneumococcal disease
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today